Biocon Biologics To Buy Viatris' Biosimilars Assets For Up To $3.335 Bln In Stock, Cash
28/2 15:20
(RTTNews) - Biocon Biologics Ltd. or BBL, a subsidiary of India-based Biocon Ltd., on Monday has entered into a definitive agreement with its partner Viatris Inc. (VTRS) to acquire Viatris' biosimilars business for a consideration of up to $3.335 billion in cash and stock to crea...